Final trial results confirm Ebola vaccine provides high protection against disease

Final results from a trial in Guinea found that the experimental rVSV-ZEBOV vaccine provided high protection against Ebola, with no cases recorded among vaccinated participants at least 10 days after vaccination. WHO and partner organizations conducted the 2015 ring-vaccination trial, whose findings strengthen prospects for responding to future outbreaks.